BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:BPI-371153 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of BPI-371153\, from ClinicalTrials.gov esti
 mates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT05341557-2418@assetmemo.bio
DTSTAMP:20261121T005828Z
DTSTART;VALUE=DATE:20261231
DTEND;VALUE=DATE:20270101
SUMMARY:BPI-371153: Phase 1 readout est. (NCT05341557)
DESCRIPTION:BPI-371153\, phase 1\, Non-Small Cell Lung Cancer.\nStudy: A Ph
 ase 1 Study of BPI-371153 in Subjects with Advanced Solid Tumors or Relaps
 ed/Refractory Lymphoma\nEstimated primary completion: December 2026. This 
 is a ClinicalTrials.gov estimate\, not a confirmed readout date\, and it c
 an move.\nDrug page: https://assetmemo.bio/drug/bpi-371153#upcoming-events
 \nRegistry record: https://clinicaltrials.gov/study/NCT05341557
URL:https://assetmemo.bio/drug/bpi-371153#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
